Surufatinib Active Not Recruiting Phase 2 Trials for Neuroendocrine Tumors / Neuroendocrine Tumour of the Lung / Small Intestinal Neuroendocrine Tumor Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04579679Open-Label Surufatinib in European Patients With NET